THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

Medicare covers one annual prostate-specific antigen (PSA) test for people with prostates if they meet the eligibility guidelines and the test is medically necessary. Medicare typically covers one ...

Study shows boosting diet with supplements could halt prostate tumour growth and help men avoid unnecessary surgery, chemo or ...

“For localised prostate cancer, treatment options include surgery or radiotherapy. Both give equivalent cure rates,” Dr Komen ...

JAMES Wylie felt perfectly well – until a routine blood test sounded the alarm and revealed a cancer that could have killed ...

Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.

Rates of prostate cancer in the United States dropped by 53% from 1992, when prostate-specific antigen (PSA) testing was widely used, to 2013, the latest year for which data are available. The finding ...